About
Technology
Issues
FAQ
Links
Official Page
Adjunction of a MEK inhibitor to Vemurafenib in the treatment of metastatic melanoma results in a 60% reduction of acute kidney injury
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.